195 related articles for article (PubMed ID: 29889862)
1. Viral load testing and the use of test results for clinical decision making for HIV treatment in Cameroon: An insight into the clinic-laboratory interface.
Awungafac G; Amin ET; Fualefac A; Takah NF; Agyingi LA; Nwobegahay J; Ondoa P; Njukeng PA
PLoS One; 2018; 13(6):e0198686. PubMed ID: 29889862
[TBL] [Abstract][Full Text] [Related]
2. Non-uptake of viral load testing among people receiving HIV treatment in Gomba district, rural Uganda.
Nakalega R; Mukiza N; Kiwanuka G; Makanga-Kakumba R; Menge R; Kataike H; Maena J; Akello C; Atuhaire P; Matovu-Kiweewa F; Ndikuno-Kuteesa C; Debem H; Mujugira A
BMC Infect Dis; 2020 Oct; 20(1):727. PubMed ID: 33023498
[TBL] [Abstract][Full Text] [Related]
3. Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya.
Kadima J; Patterson E; Mburu M; Blat C; Nyanduko M; Bukusi EA; Cohen C; Oyaro P; Abuogi L
PLoS One; 2018; 13(11):e0200242. PubMed ID: 30412576
[TBL] [Abstract][Full Text] [Related]
4. Determinants of switch to paediatric second-line antiretroviral therapy after first-line failure in Cameroon.
Njom-Nlend AE; Efouba N; Brunelle Sandie A; Fokam J
Trop Med Int Health; 2021 Aug; 26(8):927-935. PubMed ID: 33905593
[TBL] [Abstract][Full Text] [Related]
5. Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi.
Nicholas S; Poulet E; Wolters L; Wapling J; Rakesh A; Amoros I; Szumilin E; Gueguen M; Schramm B
J Int AIDS Soc; 2019 Aug; 22(8):e25387. PubMed ID: 31441242
[TBL] [Abstract][Full Text] [Related]
6. Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapy.
Kerschberger B; Boulle AM; Kranzer K; Hilderbrand K; Schomaker M; Coetzee D; Goemaere E; Van Cutsem G
J Int AIDS Soc; 2015; 18(1):20092. PubMed ID: 26403636
[TBL] [Abstract][Full Text] [Related]
7. Challenges with targeted viral load testing for medical inpatients at Queen Elizabeth Central Hospital in Blantyre, Malawi.
Craik A; Patel P; Patel P; Mallewa J; Malisita K; Bitilinyu-Bangoh J; van Oosterhout JJ; Kelly C
Malawi Med J; 2016 Dec; 28(4):179-181. PubMed ID: 28321282
[TBL] [Abstract][Full Text] [Related]
8. Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of "test and treat".
Fokam J; Sosso SM; Yagai B; Billong SC; Djubgang Mbadie RE; Kamgaing Simo R; Edimo SV; Nka AD; Tiga Ayissi A; Yimga JF; Takou D; Moudourou S; Ngo Nemb M; Nfetam Elat JB; Santoro MM; Perno CF; Colizzi V; Ndjolo A
AIDS Res Ther; 2019 Nov; 16(1):36. PubMed ID: 31744517
[TBL] [Abstract][Full Text] [Related]
9. Expanded access to viral load testing and use of second line regimens in Haiti: time trends from 2010-2017.
Wang Y; Barnhart S; Francois K; Robin E; Kalou M; Perrin G; Hall L; Koama JB; Marinho E; Balan JG; Honoré JG; Puttkammer N
BMC Infect Dis; 2020 Apr; 20(1):283. PubMed ID: 32299389
[TBL] [Abstract][Full Text] [Related]
10. Is There a Need for Viral Load Testing to Assess Treatment Failure in HIV-Infected Patients Who Are about to Change to Tenofovir-Based First-Line Antiretroviral Therapy? Programmatic Findings from Myanmar.
Thiha N; Chinnakali P; Harries AD; Shwe M; Balathandan TP; Thein Than Tun S; Das M; Tin HH; Yi Y; Babin FX; Lwin TT; Clevenbergh PA
PLoS One; 2016; 11(8):e0160616. PubMed ID: 27505228
[TBL] [Abstract][Full Text] [Related]
11. SESOTHO trial ("Switch Either near Suppression Or THOusand") - switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel-group, open-label, randomized clinical trial in Lesotho, Southern Africa.
Amstutz A; Nsakala BL; Vanobberghen F; Muhairwe J; Glass TR; Achieng B; Sepeka M; Tlali K; Sao L; Thin K; Klimkait T; Battegay M; Labhardt ND
BMC Infect Dis; 2018 Feb; 18(1):76. PubMed ID: 29433430
[TBL] [Abstract][Full Text] [Related]
12. The viral load monitoring cascade in a resource-limited setting: A prospective multicentre cohort study after introduction of routine viral load monitoring in rural Lesotho.
Glass TR; Motaboli L; Nsakala B; Lerotholi M; Vanobberghen F; Amstutz A; Lejone TI; Muhairwe J; Klimkait T; Labhardt ND
PLoS One; 2019; 14(8):e0220337. PubMed ID: 31461455
[TBL] [Abstract][Full Text] [Related]
13. Multi-site clinical evaluation of the Xpert(®) HIV-1 viral load assay.
Jordan JA; Plantier JC; Templeton K; Wu AH
J Clin Virol; 2016 Jul; 80():27-32. PubMed ID: 27135387
[TBL] [Abstract][Full Text] [Related]
14. Viral load detection and management on first line ART in rural Rwanda.
Ndagijimana Ntwali JD; Decroo T; Ribakare M; Kiromera A; Mugwaneza P; Nsanzimana S; Lynen L
BMC Infect Dis; 2019 Jan; 19(1):8. PubMed ID: 30606128
[TBL] [Abstract][Full Text] [Related]
15. The Suboptimal Pediatric HIV Viral Load Cascade: Multidistrict Cohort Study Among Children Taking Antiretroviral Therapy in Lesotho, Southern Africa.
Muhairwe JA; Brown JA; Motaboli L; Nsakala BL; Lerotholi M; Amstutz A; Klimkait T; Glass TR; Labhardt ND
Pediatr Infect Dis J; 2022 Mar; 41(3):e75-e80. PubMed ID: 34862344
[TBL] [Abstract][Full Text] [Related]
16. Virologic outcome among patients receiving antiretroviral therapy at five hospitals in Haiti.
Jean Louis F; Buteau J; François K; Hulland E; Domerçant JW; Yang C; Boncy J; Burris R; Pelletier V; Wagar N; Deyde V; Lowrance DW; Charles M
PLoS One; 2018; 13(1):e0192077. PubMed ID: 29381736
[TBL] [Abstract][Full Text] [Related]
17. Short communication: east meets west: a description of HIV-1 drug resistance mutation patterns of patients failing first line therapy in PEPFAR clinics from Uganda and Nigeria.
Crawford KW; Wakabi S; Kibuuka H; Magala F; Keshinro B; Okoye I; Akintunde E; Hamm TE
AIDS Res Hum Retroviruses; 2014 Aug; 30(8):796-9. PubMed ID: 24798614
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of near point-of-care viral load implementation in public health facilities across seven countries in sub-Saharan Africa.
Boeke CE; Joseph J; Atem C; Banda C; Coulibaly KD; Doi N; Gunda A; Kandulu J; Kiernan B; Kingwara L; Maokola W; Maparo T; Mbaye RN; Mtumbuka E; Mziray J; Ngugi C; Nkakulu J; Nzuobontane D; Okomo Assoumo MC; Peter T; Rioja MR; Sacks JA; Simbi R; Vojnov L; Khan SA
J Int AIDS Soc; 2021 Jan; 24(1):e25663. PubMed ID: 33455081
[TBL] [Abstract][Full Text] [Related]
19. Brief Report: Interferon-γ-Inducible Protein 10-A Potential Marker for Targeted Viral Load Monitoring of Antiretroviral Treatment?
Reepalu A; Arimide DA; Balcha TT; Björkman P; Medstrand P
J Acquir Immune Defic Syndr; 2020 Apr; 83(5):475-478. PubMed ID: 31917753
[TBL] [Abstract][Full Text] [Related]
20. HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.
Myer L; Phillips TK; McIntyre JA; Hsiao NY; Petro G; Zerbe A; Ramjith J; Bekker LG; Abrams EJ
HIV Med; 2017 Feb; 18(2):80-88. PubMed ID: 27353189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
